Literature DB >> 32519978

Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system.

Emine Akalın1, Miraç Ekici1, Zinar Alan1, Elif Özbir Elevli1, Aysenur Yaman Bucak2, Nuerbiye Aobuliaikemu3, Ali Yağız Üresin2.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effectiveness of plants used in the formulations of traditional Chinese medicine (TCM), which were also used in clinical trials to treat patients with the novel coronavirus COVID-19, and to assess their effects on the cardiovascular system.
METHODS: A literature review of PubMed, ResearchGate, ScienceDirect, the Cochrane Library, and TCM monographs was conducted and the effects of the plants on the cardiovascular system and the mechanisms of action in COVID-19 treatment were evaluated.
RESULTS: The mechanism of action, cardiovascular effects, and possible toxicity of 10 plants frequently found in TCM formulations that were used in the clinical treatment of COVID-19 were examined.
CONCLUSION: TCM formulations that had been originally developed for earlier viral diseases have been used in COVID-19 treatment. Despite the effectiveness seen in laboratory and animal studies with the most commonly used plants in these formulations, the clinical studies are currently insufficient according to standard operating procedures. More clinical studies are needed to understand the safe clinical use of traditional plants.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32519978     DOI: 10.5543/tkda.2020.03374

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  6 in total

1.  Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein.

Authors:  Yu-Meng Chen; Jin-Lai Wei; Rui-Si Qin; Jin-Ping Hou; Guang-Chao Zang; Guang-Yuan Zhang; Ting-Ting Chen
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Synergistic deciphering of bioenergy production and electron transport characteristics to screen traditional Chinese medicine (TCM) for COVID-19 drug development.

Authors:  Po-Wei Tsai; Cheng-Yang Hsieh; Jasmine U Ting; Yi-Ru Ciou; Chia-Jung Lee; Chieh-Lun Hsieh; Tzu-Kuan Lien; Chung-Chuan Hsueh; Bor-Yann Chen
Journal:  J Taiwan Inst Chem Eng       Date:  2022-05-12       Impact factor: 5.477

Review 3.  Insights from the Perspective of Traditional Chinese Medicine to Elucidate Association of Lily Disease and Yin Deficiency and Internal Heat of Depression.

Authors:  Bingxian Shang; Hongxiu Zhang; Yanting Lu; Xiaoyu Zhou; Yong Wang; Minghan Ma; Ke Ma
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-25       Impact factor: 2.629

4.  COVID-19 and the heart: insights from the National Societies of Cardiology Journals.

Authors:  Jean-Jacques Monsuez
Journal:  Eur Heart J       Date:  2021-10-14       Impact factor: 29.983

Review 5.  A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19.

Authors:  Robert L Chapman; Shridhar V Andurkar
Journal:  Med Chem Res       Date:  2021-12-02       Impact factor: 1.965

6.  Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis.

Authors:  Runmin Li; Ying Li; Bingchen Li; Haiyang Sun; Xinyu Liu; Xin Ge; Yuanxiang Liu; Jiguo Yang
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.